Fecal transplants for autism deliver success in clinical trials
A two-year clinical trial by Arizona State University found that fecal microbiota transplants can reduce autism symptoms by up to 45 percent in children. The treatment, which involved a bowel cleanse and daily transplants over several weeks, also led to lasting improvements in gastrointestinal issues. Symptoms continued to improve over time, with many participants moving from severe to mild or non-diagnosable levels of autism two years post-treatment.
- ▪The study involved children with autism who had lower gut microbiome diversity compared to neurotypical children.
- ▪Two years after treatment, 44% of participants fell below the cutoff for mild autism spectrum disorder.
- ▪Autism symptoms decreased by 24% at the eight-week mark and improved to 45% reduction at two years.
- ▪Gastrointestinal problems, common in autistic children, also significantly improved following the treatment.
- ▪The research is advancing to a larger Phase 3 placebo-controlled clinical trial to confirm results.
Opening excerpt (first ~120 words) tap to expand
ADHD & Autism Fecal transplants for autism deliver success in clinical trials By Rich Haridy, Nick Lavars April 21, 2025 08:03 pm Facebook Twitter LinkedIn Reddit Email / Fecal transplants for autism deliver success in clinical trials A two-year study on fecal transplants for autism has found they can reduce symptoms by as much as 45 percentArizona State University View 3 Images 1/3 New research sheds new light on the connection between gut health and autismArizona State University/Shireen Dooling 2/3 A two-year study on fecal transplants for autism has found they can reduce symptoms by as much as 45 percentArizona State University 3/3 The team of ASU researchers behind the new study, left to right, Rosa Krajmalnik-Brown, James Adams, and Dae Wook Kang were inspired to explore the…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Refractor.
Discussion
0 commentsMore from Refractor
